Return On Equity of Lexaria Bioscience Corp. from 31 Aug 2015 to 30 Nov 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Lexaria Bioscience Corp. quarterly and annual Return On Equity in % history and change rate from 31 Aug 2015 to 30 Nov 2025.
  • Lexaria Bioscience Corp. Return On Equity for the quarter ending 30 Nov 2025 was -227%, a 155% decline year-over-year.
  • Lexaria Bioscience Corp. annual Return On Equity for 2025 was -199%, a 131% decline from 2024.
  • Lexaria Bioscience Corp. annual Return On Equity for 2024 was -86%, a 44% increase from 2023.
  • Lexaria Bioscience Corp. annual Return On Equity for 2023 was -154%, a 108% decline from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Lexaria Bioscience Corp. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 -227% -138% -155% 01 Sep 2025 30 Nov 2025
Q3 2025 -199% -113% -131% 01 Jun 2025 31 Aug 2025
Q2 2025 -157% -69% -78% 01 Mar 2025 31 May 2025
Q1 2025 -112% +22% +17% 01 Dec 2024 28 Feb 2025
Q4 2024 -89% +77% +46% 01 Sep 2024 30 Nov 2024
Q3 2024 -86% +68% +44% 01 Jun 2024 31 Aug 2024
Q2 2024 -88% +36% +29% 01 Mar 2024 31 May 2024
Q1 2024 -134% -32% -32% 01 Dec 2023 29 Feb 2024
Q4 2023 -165% -82% -98% 01 Sep 2023 30 Nov 2023
Q3 2023 -154% -80% -108% 01 Jun 2023 31 Aug 2023
Q2 2023 -124% -59% -91% 01 Mar 2023 31 May 2023
Q1 2023 -102% -37% -58% 01 Dec 2022 28 Feb 2023
Q4 2022 -83% -36% -75% 01 Sep 2022 30 Nov 2022
Q3 2022 -74% -28% -61% 01 Jun 2022 31 Aug 2022
Q2 2022 -65% -9.2% -16% 01 Mar 2022 31 May 2022
Q1 2022 -64% -13% -25% 01 Dec 2021 28 Feb 2022
Q4 2021 -48% +117% +71% 01 Sep 2021 30 Nov 2021
Q3 2021 -46% +114% +71% 01 Jun 2021 31 Aug 2021
Q2 2021 -56% 01 Mar 2021 31 May 2021
Q1 2021 -52% 01 Dec 2020 28 Feb 2021
Q4 2020 -164% 01 Sep 2020 30 Nov 2020
Q3 2020 -160% 01 Jun 2020 31 Aug 2020

Lexaria Bioscience Corp. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2025 -199% -113% -131% 01 Sep 2024 31 Aug 2025
2024 -86% +68% +44% 01 Sep 2023 31 Aug 2024
2023 -154% -80% -108% 01 Sep 2022 31 Aug 2023
2022 -74% -28% -62% 01 Sep 2021 31 Aug 2022
2021 -46% +114% +71% 01 Sep 2020 31 Aug 2021
2020 -160% -286% -227% 01 Sep 2019 31 Aug 2020
2019 126% -133% -51% 01 Sep 2018 31 Aug 2019
2018 259% +370% 01 Sep 2017 31 Aug 2018
2017 -111% +984% +90% 01 Sep 2016 31 Aug 2017
2016 -1096% -916% -511% 01 Sep 2015 31 Aug 2016
2015 -179% 01 Sep 2014 31 Aug 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.